Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements

(2013) B You et al.   BRITISH JOURNAL OF CANCER

Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy

(2012) C. Lybol et al.   ANNALS OF ONCOLOGY

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia

(2012) R Agarwal et al.   BRITISH JOURNAL OF CANCER

Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009

(2012) A Sita-Lumsden et al.   BRITISH JOURNAL OF CANCER

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

(2012) C. Lybol et al.   GYNECOLOGIC ONCOLOGY

EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis

(2012) Constantine Alifrangis et al.   JOURNAL OF CLINICAL ONCOLOGY

Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations

(2012) N.J. Sebire et al.   PLACENTA

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

(2011) Raymond J. Osborne et al.   JOURNAL OF CLINICAL ONCOLOGY

What a difference an egg makes

(2011) Rosemary A Fisher et al.   LANCET

Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study

(2011) Roshan Agarwal et al.   LANCET

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1

(2010) S McGrath et al.   BRITISH JOURNAL OF CANCER

Gestational trophoblastic disease

(2010) Michael J Seckl et al.   LANCET

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study

(2009) Peter Schmid et al.   LANCET

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)

(2008) J. Wang et al.   ANNALS OF ONCOLOGY

Does chest CT matter in the staging of GTN?

(2008) Suzanne Darby et al.   GYNECOLOGIC ONCOLOGY

Current management of gestational trophoblastic diseases

(2008) Ross S. Berkowitz et al.   GYNECOLOGIC ONCOLOGY